Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GILD |
---|---|---|
09:32 ET | 357278 | 95.81 |
09:33 ET | 57705 | 96.8056 |
09:35 ET | 70344 | 96.66 |
09:37 ET | 27890 | 96.65 |
09:39 ET | 30262 | 97.03 |
09:42 ET | 26083 | 97.09 |
09:44 ET | 22116 | 96.67 |
09:46 ET | 37574 | 96.92 |
09:48 ET | 18684 | 96.88 |
09:50 ET | 31377 | 96.82 |
09:51 ET | 24895 | 96.89 |
09:53 ET | 56810 | 96.83 |
09:55 ET | 32172 | 96.71 |
09:57 ET | 41113 | 96.565 |
10:00 ET | 12122 | 96.7 |
10:02 ET | 11038 | 96.74 |
10:04 ET | 16678 | 96.93 |
10:06 ET | 30698 | 96.85 |
10:08 ET | 21574 | 97.18 |
10:09 ET | 66265 | 97.1 |
10:11 ET | 20798 | 97.16 |
10:13 ET | 45163 | 97.225 |
10:15 ET | 26369 | 96.85 |
10:18 ET | 88617 | 97.04 |
10:20 ET | 7414 | 96.89 |
10:22 ET | 25022 | 96.78 |
10:24 ET | 20309 | 96.73 |
10:26 ET | 27839 | 96.73 |
10:27 ET | 80209 | 96.485 |
10:29 ET | 23602 | 96.4759 |
10:31 ET | 181155 | 96.18 |
10:33 ET | 10240 | 96.26 |
10:36 ET | 60527 | 96.01 |
10:38 ET | 26763 | 96.035 |
10:40 ET | 40020 | 95.9 |
10:42 ET | 21429 | 95.7701 |
10:44 ET | 10656 | 96.09 |
10:45 ET | 44194 | 95.895 |
10:47 ET | 13996 | 96.0001 |
10:49 ET | 30424 | 96.08 |
10:51 ET | 16946 | 96.25 |
10:54 ET | 28875 | 96.38 |
10:56 ET | 11856 | 96.23 |
10:58 ET | 13052 | 96.28 |
11:00 ET | 14182 | 96.23 |
11:02 ET | 9764 | 96.19 |
11:03 ET | 6395 | 96.18 |
11:05 ET | 11147 | 96.21 |
11:07 ET | 11961 | 96.1819 |
11:09 ET | 16470 | 96.13 |
11:12 ET | 61914 | 96.17 |
11:14 ET | 19402 | 96 |
11:16 ET | 21331 | 95.89 |
11:18 ET | 28372 | 95.862826 |
11:20 ET | 31170 | 95.96 |
11:21 ET | 11033 | 96.14 |
11:23 ET | 19636 | 96.35 |
11:25 ET | 16149 | 96.37 |
11:27 ET | 11357 | 96.335 |
11:30 ET | 10107 | 96.48 |
11:32 ET | 16253 | 96.6 |
11:34 ET | 29508 | 96.525 |
11:36 ET | 23412 | 96.435 |
11:38 ET | 14069 | 96.41 |
11:39 ET | 11297 | 96.42 |
11:41 ET | 16725 | 96.46 |
11:43 ET | 27603 | 96.43 |
11:45 ET | 8401 | 96.385 |
11:48 ET | 9411 | 96.48 |
11:50 ET | 9985 | 96.52 |
11:52 ET | 13427 | 96.73 |
11:54 ET | 12623 | 96.7 |
11:56 ET | 12556 | 96.6125 |
11:57 ET | 9566 | 96.52 |
11:59 ET | 12972 | 96.465 |
12:01 ET | 12117 | 96.49 |
12:03 ET | 10908 | 96.36 |
12:06 ET | 8019 | 96.45 |
12:08 ET | 9687 | 96.31 |
12:10 ET | 7428 | 96.39 |
12:12 ET | 7718 | 96.36 |
12:14 ET | 7902 | 96.325 |
12:15 ET | 10821 | 96.37 |
12:17 ET | 8948 | 96.37 |
12:19 ET | 8789 | 96.375 |
12:21 ET | 7865 | 96.3876 |
12:24 ET | 8864 | 96.28 |
12:26 ET | 8432 | 96.405 |
12:28 ET | 8255 | 96.27 |
12:30 ET | 7684 | 96.36 |
12:32 ET | 8871 | 96.3402 |
12:33 ET | 15225 | 96.42 |
12:35 ET | 8545 | 96.41 |
12:37 ET | 7221 | 96.395 |
12:39 ET | 14564 | 96.36 |
12:42 ET | 3676 | 96.35 |
12:44 ET | 9703 | 96.305 |
12:46 ET | 12955 | 96.28 |
12:48 ET | 23856 | 96.33 |
12:50 ET | 8559 | 96.34 |
12:51 ET | 5600 | 96.325 |
12:53 ET | 13810 | 96.42 |
12:55 ET | 7869 | 96.5 |
12:57 ET | 10356 | 96.49 |
01:00 ET | 7365 | 96.55 |
01:02 ET | 9671 | 96.57 |
01:04 ET | 5435 | 96.505 |
01:06 ET | 7664 | 96.55 |
01:08 ET | 8547 | 96.56 |
01:09 ET | 6363 | 96.51 |
01:11 ET | 8721 | 96.565 |
01:13 ET | 18512 | 96.57 |
01:15 ET | 9999 | 96.55 |
01:18 ET | 13624 | 96.525 |
01:20 ET | 11939 | 96.45 |
01:22 ET | 7786 | 96.52 |
01:24 ET | 9901 | 96.53 |
01:26 ET | 11050 | 96.46 |
01:27 ET | 9345 | 96.45 |
01:29 ET | 11567 | 96.39 |
01:31 ET | 9633 | 96.355 |
01:33 ET | 12502 | 96.41 |
01:36 ET | 10440 | 96.36 |
01:38 ET | 8120 | 96.4 |
01:40 ET | 10530 | 96.38 |
01:42 ET | 9586 | 96.42 |
01:44 ET | 7198 | 96.33 |
01:45 ET | 7987 | 96.3 |
01:47 ET | 11530 | 96.25 |
01:49 ET | 13799 | 96.27 |
01:51 ET | 5268 | 96.29 |
01:54 ET | 9124 | 96.27 |
01:56 ET | 7364 | 96.305 |
01:58 ET | 7984 | 96.26 |
02:00 ET | 9565 | 96.225 |
02:02 ET | 10960 | 96.35 |
02:03 ET | 27591 | 96.27 |
02:05 ET | 18734 | 96.39 |
02:07 ET | 13562 | 96.32 |
02:09 ET | 5169 | 96.3 |
02:12 ET | 8860 | 96.265 |
02:14 ET | 12988 | 96.15 |
02:16 ET | 9809 | 96.245 |
02:18 ET | 7989 | 96.25 |
02:20 ET | 7024 | 96.255 |
02:21 ET | 14306 | 96.295 |
02:23 ET | 21510 | 96.35 |
02:25 ET | 7612 | 96.42 |
02:27 ET | 18581 | 96.465 |
02:30 ET | 8979 | 96.48 |
02:32 ET | 25812 | 96.57 |
02:34 ET | 15523 | 96.63 |
02:36 ET | 10202 | 96.595 |
02:38 ET | 12209 | 96.63 |
02:39 ET | 8319 | 96.71 |
02:41 ET | 11954 | 96.7 |
02:43 ET | 8543 | 96.64 |
02:45 ET | 12579 | 96.72 |
02:48 ET | 9387 | 96.7495 |
02:50 ET | 9086 | 96.65 |
02:52 ET | 7665 | 96.65 |
02:54 ET | 12803 | 96.64 |
02:56 ET | 8237 | 96.68 |
02:57 ET | 5770 | 96.7 |
02:59 ET | 14588 | 96.67 |
03:01 ET | 7875 | 96.7 |
03:03 ET | 16411 | 96.66 |
03:06 ET | 12376 | 96.6659 |
03:08 ET | 8311 | 96.64 |
03:10 ET | 9993 | 96.53 |
03:12 ET | 13076 | 96.631665 |
03:14 ET | 13306 | 96.5576 |
03:15 ET | 27820 | 96.53 |
03:17 ET | 12999 | 96.49 |
03:19 ET | 12401 | 96.48 |
03:21 ET | 11444 | 96.49 |
03:24 ET | 11820 | 96.44 |
03:26 ET | 11200 | 96.51 |
03:28 ET | 13372 | 96.5409 |
03:30 ET | 23407 | 96.6 |
03:32 ET | 15710 | 96.72 |
03:33 ET | 13858 | 96.68 |
03:35 ET | 11661 | 96.69 |
03:37 ET | 21542 | 96.66 |
03:39 ET | 14398 | 96.675 |
03:42 ET | 14650 | 96.72 |
03:44 ET | 33716 | 96.81 |
03:46 ET | 19625 | 96.81 |
03:48 ET | 15666 | 96.81 |
03:50 ET | 26387 | 96.83 |
03:51 ET | 53986 | 96.86 |
03:53 ET | 40955 | 96.92 |
03:55 ET | 91235 | 96.86 |
03:57 ET | 109928 | 96.63 |
04:00 ET | 1368142 | 96.565 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Gilead Sciences Inc | 120.3B | 1,149.7x | +1.53% |
Amgen Inc | 174.8B | 41.6x | -0.22% |
Bristol-Myers Squibb Co | 109.8B | -15.1x | +4.90% |
Haleon PLC | 42.7B | 17.7x | --- |
GSK plc | 74.3B | 23.0x | +6.39% |
Teva Pharmaceutical Industries Ltd | 19.9B | -19.6x | --- |
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The Company operates in more than 35 countries.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $120.3B |
---|---|
Revenue (TTM) | $28.3B |
Shares Outstanding | 1.2B |
Dividend Yield | 3.19% |
Annual Dividend Rate | 3.0800 USD |
Ex-Dividend Date | 09-13-24 |
Pay Date | 09-27-24 |
Beta | 0.20 |
EPS | $0.08 |
Book Value | $18.33 |
P/E Ratio | 1,149.7x |
Price/Sales (TTM) | 4.3 |
Price/Cash Flow (TTM) | 128.7x |
Operating Margin | 2.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.